FMP
LakeShore Biopharma Co., Ltd.
LSBPW
NASDAQ
LakeShore Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 2002 and is based in Beijing, China.
0.0546 USD
0.0186 (34.07%)
LSBPW Financial Statements
Quarter
2024 Q4
2024 Q3
2024 Q2
2024 Q1
Total Revenue
135.53M
168.71M
96.82M
176.27M
Cost of Revenue
101.12M
34.9M
17.51M
34.68M
Gross Profit
34.41M
133.81M
79.31M
141.59M
Operating Expenses
215.55M
217.96M
179.36M
210.17M
Research and Development
58.81M
68.24M
78.21M
100.64M
Selling, General & Administrative Expenses
62.68M
149.72M
114.3M
111.01M
Selling & Marketing Expenses
72.17M
71.34M
78.51M
79.19M
General & Administrative Expenses
9.49M
78.23M
35.8M
31.81M
Other Expenses
94.06M
0
-381.93k
-213k
Operating Income
-181.15M
-84.16M
-113.2M
-70.05M
Total Other Income/Expenses Net
-13.75M
-3.44M
7.99M
-74k
Income Before Tax
-194.9M
-87.6M
-105.22M
-70.13M
Income Tax
-13.72M
-7.45M
-234.35k
-586k
Net Income
-181.41M
-80.15M
-104.98M
-69.54M
Basic EPS
-1.72
-0.85
-1.13
-0.75
EPS Diluted
-1.72
-0.85
-1.13
-0.75
Basic Average Shares
14.85M
93.06M
93.06M
93.06M
Diluted Average Shares
14.85M
93.06M
93.06M
93.06M
EBITDA
-82.73M
-72.35M
-98.48M
-62.1M
All figures are in CNY.
